Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CEPH -- Ignore unavailable to you. Want to Upgrade?

To: GW who wrote (633)	4/7/1998 4:20:00 AM
From: Eldon	Read Replies (1) \| Respond to of 998

Currently, no one really knows what the heck is going on. People at CEPH and CHIR say that they take the news as neither positive or negative. Analysts are actually spitting out out opinions favoring approval as well as denial of Myo. The bottom line is no one knows. CEPH really needs to come out and say something here, before they lose their investors for good. This announcement was completely unexpected, and the way I understand it, there cannot be another advisory panel meeting; that is why it was "cancelled" and not postponed. At this point, Myo will be either approved/disapproved on May 11, or, worst case scenario in my opinion, the May 11th date may be delayed for further review. Whatever the case, the put/call strategy talked about even on this board is definitely the safest thing. Regardless of all the support from patients and political people, this thing has been going on for a year now remember. People are starting to get fed up and restless; so I think May will be the last straw for many either way. All we can do now is just wait for more info. Good luck to all.